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How Much TCR Does a T Cell Need?
with MHC/self-peptide complexes is required for main-Nathalie Labrecque,2 Liam Simon Whitfield,
tenance of the naive T cell pool. It has been shown,Reinhard Obst,3 Caroline Waltzinger,
employing a variety of experimental systems, that T cellsChristophe Benoist,1,3 and Diane Mathis1,3
deprived of peripheral MHC/peptide engagements haveInstitut de Ge´ne´tique et de Biologie Mole´culaire
a reduced life span (Rooke et al., 1997; Takeda et al.,et Cellulaire
1996; Kirberg et al., 1997; Brocker, 1997; Witherden etCNRS/INSERM/ULP
al., 2000; Tanchot et al., 1997; Nesic and Vukmanovic,1 rue Laurent Fries
1998); engagement of the restricting element that pro-67404 Strasbourg-Illkirch
moted positive selection in the thymus appears to beFrance
necessary (Kirberg et al., 1997; Tanchot et al., 1997;
Boursalian and Bottomly, 1999; Viret et al., 1999). Yet,
a wide range of half-lives in the absence of MHC/peptideSummary
interactions has been reported with the different sys-
tems, and it is also not clear whether CD4 and CD8Kinetic features of TCR:MHC/peptide interactions dic-
T cell populations show the same decay kinetics. Verytate their outcome in vitro, some important parameters
recently, a few reports even questioned the link betweenof which include the number of molecules engaged
MHC/peptide engagement and T cell survival (Dorfmanand the duration of engagement. We explored the in
et al., 2000; Clarke and Rudensky, 2000). TCR:MHC pep-vivo significance of these findings in transgenic mice
tide interactions also drive the homeostatic expansionexpressing TCRs in a quantitatively and temporally
that takes place in response to lymphopenic environ-controlled manner. As anticipated, reduced TCR levels
ments (Ernst et al., 1999, and references therein). Al-resulted in attenuated reactivity, but response thresh-
though proliferation in this context appears to be a re-olds were substantially lower than expected—at as
sponse to environmental cues signaling that the T celllow as 1/20th the normal TCR numbers and with no
compartment is not full, TCRs vary in their ability toindication of phenotypic skewing at suboptimal levels.
promote homeostatic proliferation, suggesting that theWe also studied survival of T lymphocytes stripped
affinity/avidity constants of MHC/self-peptide recogni-of their TCRs. Unlike B cells, T cells lacking antigen
tion may come into play (Ernst et al., 1999; Goldrath andreceptors did not die precipitously; instead, popula-
Bevan, 1999; Rocha and von Boehmer, 1991; Clarke andtions decayed gradually, just as previously reported
Rudensky, 2000; Kieper and Jameson, 1999; Oehenin the absence of MHC molecules.
and Brduscha-Riem, 1999; Ferreira et al., 1999; Surh
and Sprent, 2000; Correia-Neves et al., 2001).Introduction
Finally, active proliferation and terminal differentiation
into effector cells are provoked by antigens presented asThe interaction between TCRs expressed by T cells and
short peptide fragments encased within MHC moleculesMHC/peptide complexes displayed on various cell types
displayed on antigen-presenting cells (APCs). The signalis the crux of T lymphocyte differentiation and acquisi-
induced by these strong agonist ligands is somehowtion of effector functions. Appropriate gauging of the
read as being different from the “tickling” by MHC/self-quantity and quality of TCR:MHC/peptide engagements
peptide complexes that promotes the positive selectionconditions the choices T cells make throughout their life
and survival of T cells, and the resulting proliferativecycle.
response can be explosive. Again, the strength of the
In the thymus, the newly assembled TCR of immature
signal imparted through the TCR impinges on the differ-
thymocytes interacts with MHC/self-peptide complexes
entiative choice. Cytokine and costimulatory influences
on stromal epithelial cells. If strong, this engagement on responding T cells certainly play a key role in coaxing
results in clonal deletion of thymocytes by apoptosis. If them toward a Type 1 (Th1, Tc1) versus Type 2 (Th2, Tc2)
within an “acceptable” range of avidity, the outcome is phenotype, but there is also evidence that the strength/
positive selection and differentiation into mature, ex- quality of the TCR signal can exert an important influ-
portable T cells. If engagement is weak or absent, imma- ence (Hosken et al., 1995; Constant et al., 1995; Tao et
ture thymocytes quickly die of neglect. The affinity/avid- al., 1997; Rogers and Croft, 1999; Pfeiffer et al., 1995).
ity criteria that define acceptable are still unclear, as Thus, in these many instances, the TCR appears to
are the factors that condition commitment to the CD4 act as a sensitive rheostat, translating the affinity/avidity
versus CD8 lineage. of engagement into signals that somehow specify differ-
In peripheral lymphoid organs, continued interaction ential cell activity and/or fate. The agonist/antagonist
nature of MHC/peptide complexes has generally corre-
1 Correspondence: cb@joslin.harvard.edu (C.B.), dm@joslin.harvard. lated with differences in the off rate of the complexes
edu (D.M.) they form with TCRs in vitro (Alam et al., 1996; Sykulev
2 Present address: Centre de Recherche Guy-Bernier, 5415 Boule- et al., 1994; Matsui et al., 1994; Lyons et al., 1996),
vard de l’Assomption, Montre´al, Que´bec H1T 2M4, Canada.
differences that result in variable duration of productive3 Present address: Section on Immunology and Immunogenetics,
interactions. The duration of TCR engagement doesJoslin Diabetes Center, and Department of Medicine, Brigham and
seem to have an important effect on its outcome, be itWomen’s Hospital, Harvard Medical School, Boston, Massachusetts
02215. in the context of lineage commitment in association with
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positive selection or of effector phenotype choices dur- Transgenic mice carrying each construct were gener-
ated by independent microinjection. After analyzing theing the activation of peripheral T cells (Yasutomo et al.,
specificity and levels of transgene expression in off-2000; Iezzi et al., 1998; Valitutti et al., 1995a). The number
spring from various lck-tTA founders (data not shown),of TCR molecules engaged may be another key parame-
we selected one line, LTH1, whose properties are de-ter of the interaction, having been directly correlated
tailed in Figure 1. According to Northern blot analysiswith the outcome (Valitutti et al., 1995b; Matsui et al.,
(Figure 1B), the LTH transgene was active only in1994; Lanzavecchia et al., 1999). It has been proposed
lymphoid organs (with the exception of a weak signalthat distinct thresholds, tunable by the concomitant in-
in the ovaries). Transcripts were localized more preciselyfluence of costimulatory molecules, are required for dif-
in the thymus and lymph nodes by in situ hybridizationferent phenotypic responses (Valitutti et al., 1996; Itoh
with a tTA-specific probe (Figure 1C). As might be ex-and Germain, 1997). As a large number of productive
pected, the thymic cortex labeled more intensely thaninteractions (5,000–20,000) seems to be needed, serial
the medulla, attributable to a lower density of T cells inengagement of the limited number of MHC molecules
the medulla compared with the cortex (a pattern charac-loaded by the cognate peptide on each APC (in the
teristic of other probes corresponding to TCR compo-hundreds at best) has been hypothesized.
nents, such as CD3 [data not shown]). tTA mRNA couldThe above conclusions frequently derived from in vitro
be detected only in the T cell areas of the lymph nodes,experiments that entailed selecting cells with diverse
being largely excluded from the B cell follicles. A moreTCR levels as the result of a prior exposure to antigen.
quantitative assessment of tTA transcription in thymo-It seems important to readdress some of the key ques-
cytes was performed by RT-PCR analysis of sorted sub-tions in vivo, in an experimental system where TCR levels
populations (Figures 1D and 1E). tTA was transcribedcan be varied without intentional prior triggering. Thus,
in roughly equivalent amounts in CD4CD8 double-exploiting a tetracycline (tet)-based control system
negative (DN), CD4CD8 double-positive (DP), and ma-(Furth et al., 1994; Kistner et al., 1996), we generated
ture CD4CD8 and CD4CD8 single-positive (SP)transgenic mice expressing TCRs in a quantitatively and
cells. Among DNs, transcripts were detected in all fourtemporally regulated fashion and studied T cell re-
subpopulations delineated by the CD25 and CD44 differ-sponses to antigen challenges. We also used these ani-
entiation markers, implying that the LTH-1 transgenemals to reinvestigate survival issues, in a system where
was active quite early in T cell differentiation, consistentCD4 and CD8 T cells can be studied in parallel and
with a recent analysis of lck proximal promoter activityin the absence of external perturbations.
(Buckland et al., 2000).
The LTH1 transgene (hereafter abbreviated as L) wasResults
then bred into the TetO-TCR-OT1 transgenic mice (re-
ferred to as TAO, for Tet-controlled Alpha OT-1 TCR) toTet-Responsive TCR Transgenic Mice
yield animals with regulatable TCR expression (L/TAOTo determine the influence of TCR levels on T cell re-
double-transgenic mice). We also introduced into thesesponsiveness, we generated transgenic mice in which
crosses the TCR knockout mutation (Philpott et al.,
the expression of a transgene-encoded TCR of defined
1992; hereafter abbreviated as C), which eliminates
specificity could be modulated after a normal T cell
endogenously encoded TCR  chain expression and
compartment had been established. We chose the OT-1
thereby T cell maturation beyond the DP stage; thus,
receptor—specific for the OVA257-264 peptide, Kb- positive selection and the appearance of fully mature
restricted (Kelly et al., 1993), composed of a V2/V5 T cells in L/TAO/C animals must reflect transgene-
chain combination, and the focus of numerous studies. encoded TCR expression. Lymph node T cells from
Mice expressing the OT-1  chain under tet control were such mice were examined by flow cytometry (Figure 2A).
generated using the binary transgenic strategy devel- As expected, the reporter transgene alone could not
oped by Bujard and collaborators (Kistner et al., 1996; complement the TCR deficiency: mature T lympho-
Furth et al., 1994). The first transgene encodes a tet- cytes were not found in significant numbers in TAO/
sensitive activator, the second a reporter whose expres- Co mice. Therefore, this tet-regulatable system is not
sion is controlled by the transactivator. The combination “leaky.” Addition of the LTH-1 transactivator transgene
of transgenes employed in the present study is illus- led to full restoration of peripheral CD4 and CD8 T
trated in Figure 1A. First, the lck proximal promoter was cell populations in L/TAO/Co mice. Expression of the
used to drive T cell-specific expression of the TetR-VP16 transgene-encoded TCR was demonstrated by staining
transactivator (tTA). This lck promoter-driven vector is with an anti-V2 reagent: all T cells stained positively,
active in T-lineage cells, although expression in mature most of them at levels comparable with those of wild-
cells varies between different founder lines (Chaffin et type mice (68% of WT levels on average). The relatively
al., 1990; Sohn et al., 1998). Second, the cDNA encoding low proportion of CD8 T cells in L/TAO/Co mice was
the OT-1  chain was placed under the control of a expected because the OT-1 TCR  chain has been asso-
minimal promoter augmented with seven TetO se- ciated with preferential selection into the CD4 lineage
quences. Expression of tTA in T cells should turn on (M. Correia-Neves, personal communication). The OT-1
transcription of the TCR  chain, and this transactivation TCR  chain transgene was then introduced to allow
should be sensitive to tet, which inhibits tTA binding to assembly of the complete OT-1 receptor in V5/L/TAO/
the TetO motif. To complete the OT-1 TCR, we also Co mice (third dot plot), yielding a dominant popula-
employed a third transgene encoding the OT-1 TCR  tion of CD8 T cells, as anticipated for a Kb-restricted
chain and expressed constitutively in all T cells (Correia- TCR. Again, all T cells expressed V2. The lymphocytes
whose maturation was induced by transgene expressionNeves et al., 1999).
Regulatable TCR Expression
73
Figure 1. Constructs and Transactivator Expression
(A) Constructs. Top: the lck-tTA transactivator transgene: the microinjected fragment contains the lck proximal promoter (Chaffin et al., 1990)
(gray bar), the tTA transactivator (solid bar), and several exons of the human growth hormone gene (white bars). Bottom: the TetO-TCR-OT1
reporter transgene: the fragment contains the TCR cDNA from the OT-1 hybridoma (Kb-restricted, OVA specific) (solid bar), a minimal
cytomegalovirus promoter (gray bar) linked to seven TetO sequences (hatched bars), and the rabbit -globin intron/exon and polyadenylation
sequences (white bar). B, BamHI; Bs, Bst1107i; C, ClaI; E, EcoRI; N, NotI; X, XhoI; Xb, XbaI; hGH, human growth hormone; mcs, multiple
cloning site; and polyA, polyadenylation site. The numbers in parentheses indicate the positions of restriction enzyme sites.
(B–E) tTA transgene expression in LTH1 mice. (B) Northern blot analysis of tissue RNA, hybridized with probes specific for tTA (upper panel)
and a riboprotein as control (lower panel). Organs were testes (TE), ovary (O), brain (B), heart (H), kidney (K), liver (LI), lung (LU), skeletal
muscle (M), spleen (S), and thymus (T). (C) In situ mRNA expression in mesenteric lymph nodes (LN) and thymus (Th). Sections were hybridized
with a tTA anti-sense probe. F, B follicles; M, medulla; and C, cortex. (D) Semiquantitative RT-PCR analysis of tTA mRNA expression in
CD4CD8 (DP), CD4CD8 (SP4), and CD4CD8 (SP8) thymocytes. (E) CD4CD8 thymocyte subpopulations. Hprt mRNA levels are shown
to control for amounts. RT-PCR was performed on serial dilutions (1/10) of cDNA from the different sorted populations with primers specific
for the tTA or hGH sequences.
had the phenotypic characteristics of naive T cells— pressed the transgene-encoded TCR  chain, more than
double the background of endogenous V2 expression.CD25CD69CD44CD62Lhi and little cycling (data not
shown). As expected, the presence of a transgene-encoded V5
chain boosted selection into the CD8 compartment.Thus, the combination of transgenes seemed to func-
tion as had been hoped for: expression of the OT-1 TCR We then asked whether TCR levels were responsive
to treatment of the mice with tet. The effect was quitewas transactivator dependent, at levels sufficient for
selection and maintenance of a normal complement of graphic, as illustrated in Figure 3A. While sizeable num-
bers of thymocytes were positively selected into the SPT cells. L/TAO/C mice also showed normal thymocyte
subsets, including ample populations of mature CD3hi compartments of the untreated V5/L/TAO/Co mouse
(upper right), a 3 week course of tet treatment com-cells absent from Co littermates (Figure 2B), with the
TCR density expected of thymic subsets. In V5/L/TAO/ pletely eliminated SP cells in its littermate (lower right).
The absence of mature thymocytes correlated with theCo mice, the anti-CD4/CD8 staining pattern on gated
TCRhi cells (Figure 2C) revealed the existence of a large shutdown of TCR expression in DP thymocytes (data
not shown). It did not represent a toxic effect of the drugpopulation of transitional CD48lo cells as is typical for
the OT-1 TCR (Hogquist et al., 1994). itself, since the same treatment had no effect in a wild-
type control.It was also important to assess the efficiency of L/TAO
expression in a situation where the transgene-encoded To measure the rate of extinction of TCR expression
in peripheral T lymphocytes, L/TAO mice were treatedproduct competes with the products of endogenous
TCR loci. The histograms in Figure 2D illustrate that with a high dose (1 mg/ml) of tet, and blood samples
were collected at different times and stained with anapproximately 15%–25% of CD4 and CD8 T cells ex-
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Figure 2. T Cell Compartments
(A) CD4/CD8 profiles of lymph node cells from wild-type, TAO/C, L/TAO/C, and V5/L/TAO/C mice. Juxtaposed small histograms display
the expression of the V2 chain encoded by the TetO-OT1 transgene in CD4 and CD8 T cells.
(B) Thymocyte differentiation in L/TAO/C and V5/L/TAO/C mice: CD4/CD8 profiles are in the left-most panels; V2 expression for the
different gated populations are to the right of them.
(C) CD4/CD8 profiles on gated V5-high cells from a V5/L/TAO/C thymus.
(D) Expression of the inducible OT-1 TCR chain in lymph node T cells of C-wild-type mice: CD4/CD8 profiles of lymph node cells from wild-
type, L/TAO, and V5/L/TAO mice (left panel); V2 expression on gated CD4 or CD8 cells in the middle and left histograms. The percentage
of CD4 and CD8 cells in each dot plot is shown and the percentage of V2 T cells is indicated on the histograms for C-wild-type mice.
All stainings were performed on mice that were not tet treated.
anti-V2 mAb. A significant decrease in TCR levels was CD4 and CD8 T cells. Quantitative flow cytometry with
calibrated beads as standards (Davis et al., 1998) (Figureobserved already after 4 days of tet treatment, and ex-
pression reached baseline values by day 14 (Figure 3B). 3C) showed about 40,000 molecules on wild-type CD4
cells, in good agreement with previous reports (Blich-As expected, cells expressing endogenous V2 showed
no such drop. The same kinetics were observed for feldt et al., 1996; Schodin et al., 1996; Valitutti et al.,
Regulatable TCR Expression
75
Figure 3. Tet-Controllable TCR Expression
(A) Lack of mature thymocytes in V5/L/TAO/C mice after tet treatment. Wild-type (left panels) or V5/L/TAO/C animals (right panels)
were treated (lower panels) with 1 mg/ml of tet for a 3 week period or not (top panels) and their thymi were stained for CD4 and CD8.
(B) Disappearance of TCR expression following tet treatment. Overlay histograms for V2 expression in LTAO mice are shown for CD4 or
CD8 PBL of a single mouse sampled at day 0, 4, 7, 11, 14, and 18 after initiation of tet administration (1 mg/ml in drinking water).
(C) Quantitation of the number of TCR molecules expressed by CD4 T cells during the course of tet treatment (from [B]).
1995b); 30,000 molecules/cell were found on CD4 cells were challenged by intravenous injection of the anti-
genic peptide SIINFEKL. Two doses were used: 0.1 g,from untreated L/TAO mice. Within 2 weeks after initia-
tion of tet treatment, L/TAO cells were essentially de- which is near saturating for the induction of a prolifera-
tive response in mice expressing the normal comple-nuded of TCRs. A careful analysis of TCR levels over
long periods of tet treatment revealed that while the ment of OT-1 TCRs; and 20 g, a 100-fold excess. This
bulk of molecules had disappeared by 14 days, a very
low residual expression (equivalent to 200-300 mole-
cules/cell) persisted beyond that time and was stable
for months. This low-level persistence, also observed
when the cells were stained with anti-CD3 or anti-TCR
reagents, was distinguishable from the background
seen with irrelevant antibody staining and was absent
from nontransgenic mice. It is not clear what biochemi-
cal form or functional relevance these long-lived TCR
molecules might have, although they are clearly incapa-
ble of signaling in response to antigenic stimulation (see
below) or to promote positive selection in the thymus
(Figure 3A).
Graded doses of tet were then used to quantitatively
regulate TCR expression levels in V5/L/TAO/Co mice.
The protocol, chosen for its reliability, was to leave
the animals with no tet (permitting full TCR expression)
for their first 3 weeks of life and then to switch them
to 0, 5, 10, or 400 g/ml of tet for 2 weeks or more.
TCR expression was maintained stably at intermediate
levels in animals treated with these low tet doses and levels
correlated with tet concentration (Figure 4). TCR levels
could thus be “adjusted” to 20- to 40-fold below normal
(using cells expressing endogenous V2 as an internal
standard).
Figure 4. Tet Dose-Dependent Expression of the TCR in V5/L/TAOTCR Density and T Cell Responsiveness
MiceThe possibility of regulating TCR levels, both quantita-
(A) The overlay histogram represents the expression of the trans-tively and temporally, in these transgenic mice permitted
gene-encoded  chain by lymph node CD8 T cells from V5/L/us to analyze the influence of TCR density on T cell
TAO mice treated for 2 weeks with different tet doses (0, 5, 10, andresponses in vivo. To quantitate TCR levels in individual
400 g/ml) in a representative experiment.
experimental mice, a single inguinal lymph node was (B) Quantitation of the number of TCR molecules using standardiza-
surgically removed from V5/L/TAO animals fed differ- tion microbeads containing a known number of fluorescent mole-
cules.ent tet doses. Two days after the biopsy, the animals
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Figure 5. T Cell Responses in V5/L/TAO Mice Expressing Various TCR Levels
V5/L/TAO animals treated with different doses of tet for 16 days were immunized with 0.1 g (A) or 20 g (B) SIINFEKL peptide intravenously,
and T cell responses were analyzed 48 hr later. The histograms, from left to right, show BrdU incorporation, IFN-, IL-2, and IL-4 production
by CD8 mesenteric lymph node T cells from control nontransgenic (thin line), and V5/L/TAO (thick line) mice. TCR densities are indicated
at the left (determined as above). The tet doses were 0, 5, 10, and 400 g/ml (from top to bottom). The fifth line of histograms shows results
for an immunized nontransgenic control mouse (WT).
response is dependent on both TCR transgenes (there of Figure 6. At the high antigen dose, the cycling of T
cells with even very low TCR density resulted in ais no response in mice or cells expressing the V5 trans-
gene together with endogenous V chains [data not marked expansion of the CD8 compartment. At the low
antigen dose, there was more of a correlation betweenshown]). The antigen induces a downmodulation of the
transgene-encoded TCR (4-fold at the lowest dose, the degree of proliferation and TCR levels. In addition,
cytokine responses seemed to correlate more with anti-complete at the highest). To test for proliferation, we
injected the animals with bromodeoxyuridine (BrdU) 34 gen dose than with TCR numbers. This was particularly
clear for IL-2.and 42 hr after immunization and sacrificed them at 48
hr. Spleen and lymph node T cells were stained for BrdU In short, not only was the threshold of TCR density
for responsiveness to antigen surprisingly low, but theincorporation. As illustrated in Figure 5A, the lowest
doses of immunizing peptide elicited significant prolifer- intensity of the response seemed more cued on the
density of antigen ligands than on the number of TCRsation only in mice exhibiting the two highest TCR densi-
ties. Perhaps surprisingly, mice with as few as 500–1000 available to engage them.
TCR molecules per CD8 T cell responded, although
substantially only at the high immunogen dose. In no Turnover of CD4 and CD8 T Cells in the Absence
of TCR Expressioncase did we see any proliferation, beyond that observed
with unimmunized or nontransgenic mice, in animals Given the profound and fairly rapid shutdown of TCR
expression that can be induced in L/TAO mice and thetreated with the maximum tet dose, indicating that the
residual TCR molecules displayed by these cells did not loss of thymocyte positive selection and peripheral T
cell responsiveness that ensues, it seemed worthwhilesuffice to induce a response to even a high density of
agonist ligand. to exploit this system to investigate the in vivo fate of
mature T cells denuded of TCRs subsequent to undergo-Cytokine production was also examined by intracy-
toplasmic staining of the same cells 48 hr after immuni- ing a normal selection process. As discussed above, a
number of investigators have claimed that persistentzation. Substantial IL-2 and -IFN induction was seen
only at the high dose of immunizing peptide. The propor- engagement of TCRs by MHC/self-peptide complexes is
necessary for the long-term survival of naive peripheral Ttion of positive cells and cytokine levels decreased with
diminishing TCR density, but cytokines were still clearly cells, although population decay kinetics have varied
for CD4 and CD8 cells, and of late there has beendetectable in cells displaying 1000 surface TCR mole-
cules. Importantly, the decreased -IFN expression in some debate on the whole issue. Furthermore, a recent
study (Lam et al., 1997) reported that B cells show amice showing a low TCR density did not correlate with
an induction of IL-4, absent in all mice examined except strikingly rapid demise after elimination of their surface
Igs via inducible gene targeting, as if the very presencefor untreated animals receiving the highest peptide
dose. of an assembled antigen receptor is required for B cell
survival. We wondered whether a parallel shutdown ofThese points are highlighted in the compiled indices
Regulatable TCR Expression
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Figure 6. TCR Density and T Cell Respon-
siveness
CD8 T cell divison factor (upper left), CD8
T cell number (upper right), IFN- production
index (bottom left), and IL-2 production index
(bottom right) following intravenous immuni-
zation with SIINFEKL peptide are plotted as
a function of the number of TCR molecules
on the surface of T cells. The division factor
was determined using the percentage of
BrdU cells and correcting for cells that had
divided more than once (see Experimental
Procedures); CD8 T cell numbers were
quantitated for mesenteric lymph nodes; cy-
tokine production indices were calculated
from the percentage of cytokine-positive
cells and their level of expression (see Experi-
mental Procedures). The number of surface
molecules/cell was determined as in Figure
4. The control values obtained with totally
shutoff expression (“off”) or in nontransgenic
mice (NT) are shown.
TCR expression on T cells (though by another genetic needed to substantially shut down surface TCR levels,
visible as a lag in the upper right panel, for example.trick) would rapidly precipitate their death.
These experiments were performed on L/TAO or V5/ Calculated half-lives were 26.8 and 19.0 days for CD4
and CD8 populations, respectively (bottom panels).L/TAO mice harboring a wild-type endogenous TCR
locus, thereby allowing for sizeable populations of ma- These values are quite consistent with those obtained
by most investigators for T cells placed in an MHC-ture T cells that do or do not express the inducible
TCR transgene (Figure 2D). The behavior of transgene- deficient environment. Thus, the life expectancy of T
cells without TCRs is remarkably similar to that in thepositive cells “in a crowd” of cells expressing other clo-
notypes should more closely mimic the normal situation absence of MHC/self-peptide ligands.
and avoid complications due to the “homeostatic” prolif-
eration in a lymphopenic setting. T cells that have lost Discussion
TCR expression can easily be monitored by staining
with anti-CD3 and anti-CD4 or -CD8 mAbs, registering The combination of transgenes engineered for these
studies performed as we had hoped. The OT-1 TCR as CD3-negative, CD4-, or CD8-positive cells (Figure
7A). Both L/TAO and V5/L/TAO animals were used be- chain was expressed at near-normal levels in the ab-
sence of tet and effectively promoted the selection andcause CD4 and CD8 T cells predominate in the former
and latter, respectively (Figure 2). The animals were al- maintenance of CD4 and CD8 T cells. The partitioning
of T cells into thymic and peripheral subsets mimickedlowed to generate normal lymphocyte compartments
until 6 weeks of age, when TCR expression was shut the peculiarities of the original OT-I TCR transgenic line
(Hogquist et al., 1994). Upon high-dose tet treatment,off. T cell numbers and phenotypes were then followed
over time in individual mice by sequential surgical re- TCR expression was extinguished over a matter of days;
it could also be maintained at intermediate levels withmoval of single lymph nodes (inguinal and axillary nodes,
which we find to have essentially identical cell numbers limited tet doses. While it has not been possible to repro-
duce in mice the 1000-fold dynamic range of reporterin individual control mice over time), followed by cytoflu-
orimetry. Since tet administration also halts thymic posi- gene expression reported for tissue culture transfec-
tants, the 20-fold range in TCR display does allow verytive selection (Figure 3), these experiments tracked the
survival of peripheral T cells without the complicating useful analyses. This system offers the possibility of
modulating or eliminating TCR:MHC/peptide contactsinfluences of thymocyte export.
A reproducible decline in both the CD4 and CD8 in a noninvasive manner, in an otherwise normal environ-
ment, in particular without the perturbations implicit inpopulations of individual mice was observed (Figure 7B).
This was not due just to the tet treatment, because no cell labeling and transfer protocols.
loss of T cells was observed in control animals that
drank the same antibiotic-laced water (open triangles). Number of TCRs Needed for T Cell Responsiveness
Very few surface TCR molecules (1000 or less) wereThe decay was also not due to toxicity of the residual,
unpaired TCR chain, as there are numerous examples needed for T cells to respond to immunization in vivo,
and the density/response relationship was surprisinglyof fully viable cells expressing unpaired TCR chains
(Mertsching et al., 1997; Saint-Ruf et al., 1994). The data nonexponential. This was true when suboptimal tet
treatments resulted in a low level of TCR expressionwere replotted after normalization on the starting T cell
number for each mouse and exponential curve fitting, (Figures 4 and 5) and also when mice were immunized
8 days after tet administration, when incomplete shutofftaking day 8 as the starting point to account for the time
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Figure 7. Decay of CD4 and CD8 T Cells Stripped of TCR Molecules
(A) Representative profiles of gated CD8-positive cells of a single V5/L/TAO mouse, from individual lymph nodes surgically removed at
different times of high-dose tet treatment.
(B) The proportion of transgene-expressing CD4 or CD8 T cells from tet-treated L/TAO (black circles), V5/L/TAO (black squares), or control
(open triangles) mice was determined as in (A); transgene-expressing T cells were identified as CD3 cells after the shutoff.
(C) Regression analysis of the data from (B), normalized on the pretreatment value for each mouse. To account for the 7–10 day delay before
the surface TCR is effectively cleared, the regression assumes that the decline initiates on day 8. The half-life of the T cell population is
indicated.
still left a thousand or so molecules at the cell surface sufficient for target killing by a CTL clone in vitro. There
is also an interesting parallel with patients carrying mu-(data not shown). One might argue that a minor fraction
of the cells was still displaying intermediate to high TCR tations in the CD3	 gene, some of which have T lympho-
cytes with low TCR levels but comparatively robust Tlevels in treated mice and accounted for the responses
observed. However, this is very unlikely. For example, cell function (Soudais et al., 1993). On the other hand,
they contrast with reports that T cell reactivity showedin the mouse with a mean level of 450 molecules per
CD8 cell, the 40% of cells that incorporate BrdU or a marked dependence on TCR density, in particular one
describing up to a 104-fold drop in antigen sensitivityproduce -IFN 48 hr after immunization cannot have
been generated from the gaussian trail (5%) of cells when the number of TCR molecules/cell was lowered
from 25,000 to 8,000, reflected in a highly exponentialthat express more than 5000 molecules in this mouse
(particularly as only 50% of cells respond even at full density/response profile (Viola and Lanzavecchia, 1996;
Blichfeldt et al., 1996). In most of these experiments,TCR levels). These results are consistent with those from
studies that employed laser-mediated micromanipula- however, cells of varying TCR densities were obtained
by 3 day preculture with antigen to induce TCR downmo-tion in vitro to show that the engagement of 200–400
TCR molecules by anti-CD3 was sufficient to induce a dulation; this manipulation may have conferred a refrac-
tory state on the T cells. Another explanation for therobust Ca flux (Wei et al., 1999). Schodin et al. (1996)
had also shown that a lower number of active TCR was differences may be a strong influence of costimulatory
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and adhesion molecules active in the natural in vivo al., 2000). If anything, the opposite is true (Niedergang
et al., 1997). Our results render serial engagement un-setting, amplifying the response and lowering the num-
bers of TCRs that need to be engaged. Indeed, the necessary, as it is not 10,000 to 20,000 TCR molecules
that must be engaged to elicit activation, but only severalclones used by Viola and Lanzavecchia were CD28 neg-
ative, and costimulatory molecules tuned the T cells to hundred. Thus, these results are compatible with models
in which TCR:MHC/peptide complexes form on a onelower thresholds for activation in these assays. Finally, it
is also conceivable that T cells “adapt” to progressively to one basis and persist monogamously for a long time
thereafter, as in an immunological synapse.lower TCR levels by an increased sensitivity of down-
stream signal transduction pathways, an adaptation
perhaps not possible in the time frame of the in vitro Can T Cells Survive without TCRs?
experiments. Initially, yes. Our results on the decay of TCR-negative
T cells face a daunting challenge in maintaining speci- T cell populations differ significantly from those on Ig-
ficity: the TCR recognizes its MHC/peptide ligand with negative B cells (Lam et al., 1997). The latter died precipi-
very low affinity, there is often only a limited number of tously, such that it was essentially impossible to visual-
the specific ligand molecules available on APCs in vivo, ize B cells devoid of surface Igs in cytometric profiles. In
and TCR:MHC/peptide engagement must persist over contrast, denuded CD4 and CD8 T cells were readily
tens of hours. How can TCR:MHC/peptide interactions observed (Figures 3B and 7A). These divergent out-
with half-lives on the order of 10 s account for such comes may well stem from differences in the physiology
prolonged cellular interactions? Some element of TCR of B and T cells. On the other hand, it is conceivable
and MHC/peptide clustering has been invoked (re- that the downmodulation of MHC class I molecules in-
viewed in Germain, 1997; Dustin and Chan, 2000). Two duced on B cells when their Igs were lost (Lam et al.,
different lines of reasoning have been advanced. First, 1997) rendered them efficient NK cell targets soon after
TCRs and MHC molecules may have a natural propen- the gene excision event, accelerating their death.
sity to dimerize, there being some structural data in The CD4 and CD8 T cell populations decayed pro-
support of this notion (Brown et al., 1993; Fernandez- gressively after extinction of TCR expression. This be-
Miguel et al., 1999; Reich et al., 1997); productive TCR havior is consistent with results from diverse experimen-
triggering would entail crosslinking via multimerization tal setups indicating that CD4 T cells have only limited
of the TCR and MHC molecules into stable two-dimen- survival potential in the absence of MHC molecules, with
sional “pseudo-crystals” (reviewed in Germain, 1997). a half-life very similar to that observed here (Takeda et
Here, the TCR:MHC/peptide complexes would drive the al., 1996; Rooke et al., 1997; Witherden et al., 2000). It
clustering, possibly through preformed TCR dimers or contrasts with the long-term persistence of naive CD4
multimers, as recently suggested for antigen receptors T cell pools in thymectomized mice. Recent experi-
on B cells (Schamel and Reth, 2000). The second pro- ments, however, did not detect any differences in popu-
posal is the “immunological synapse” concept: shortly lation decay when CD4 T cells were directly transferred
after initial TCR:MHC/peptide contact, a major re- into MHC-proficient and -deficient hosts, and invoked
arrangement of the cytoskeleton draws TCR molecules possible artifacts due to homeostatic proliferation to
explain the discrepancy with prior results (Clarke andinto the center of a “bull’s eye” formation. The cytoskele-
tal reorganization induced by the very first contacts Rudensky, 2000; Dorfman et al., 2000). Our data serve
to reaffirm the need for TCR:MHC/peptide engagementwould be the driving force that clusters TCR molecules,
whether or not they have already been engaged (re- for the maintenance of naive T cell pools. Proliferation
did not play a role in our experiments, as significantviewed in Dustin and Chan, 2000). Our results are clearly
more consistent with the latter proposal: a model invok- cycling was not observed, whether or not the cells had
been exposed to tet (Figure 5). It is probably more thaning a higher order assembly driven by the crosslinking
of TCR molecules themselves would be more highly a concidence that the two dissenting results came after
simple transfer of CFSE-labeled cells, rather than thedependent on TCR density; on the contrary, cytoskeletal
herding of TCR molecules into the synapse could be far more elaborate experimental protocols that generated
peripheral T cell populations via natural export of thymo-less dependent, drawing on whatever molecules the cell
displays. cytes (Takeda et al., 1996; Rooke et al., 1997; Witherden
et al., 2000).A few years ago, the serial engagement model was
advanced to explain the seeming paradox of thousands Comparison of the results from different experimental
systems has given the impression that populations ofof TCR molecules being engaged by only a few hundred
MHC/peptide ligands (Valitutti et al., 1995b; Viola and CD8 T cells decay more rapidly than CD4 populations
when deprived of their MHC/peptide ligands (discussedLanzavecchia, 1996). The key assumption underlying
this model, that each molecule downmodulated from in Witherden et al., 2000). However, in all of these sys-
tems, only one or the other of the two compartmentsthe cell surface upon activation, was one that had been
productively engaged and resultingly internalized. This could be studied. The results reported here, exploiting
an experimental setup that permits simultaneous analy-plausible interpretation was supported by a close corre-
lation between the degree of downmodulation and the sis of the CD4 and CD8 populations, argue for decay
kinetics of the same order, only slightly faster for CD8extent of cell activation. Recent results make one ques-
tion this interpretation, however, as TCR downmodula- cells. This conclusion bolsters prior proposals (Murali-
Krishna et al., 1999; Dorfman et al., 2000) that the near-tion is now shown to result from an absence of reexpres-
sion instead of an induced internalization, with no instantaneous disappearance of CD8 T cells described
in certain cases (e.g., Tanchot et al., 1997) may have beenevidence that individual TCR molecules that fail to be
reexpressed are those that have been engaged (Liu et complicated by rejection phenomena.
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node was taken before the beginning of tet treatment, and threeOur findings show that quantitative relationships be-
other data points were collected at various times by removal of thetween TCR density and T cell responsiveness that were
left inguinal, and right and left axillary lymph nodes. The mesentericclear in in vitro settings did not hold in an in vivo environ-
lymph nodes were taken at the time of sacrifice. When more than
ment, likely due to the influence of elaborately structured six points are shown, the other data derive from blood sampling,
microenvironments and the opportunity for the full pano- taken in between the removal of lymph nodes. Cells were stained
with anti-CD4-PE, anti-CD8-Tricolor, and anti-CD3 (KT3) followedply of costimulatory and adhesion molecules to impinge
by goat anti-rat-FITC.on the process. Likewise, a striking characteristic of B
cells denuded of their antigen receptors was not a fea-
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